Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

Rozanolixizumab, an Anti-FcRn Antibody: Final Results from a Phase II, Multiple-Dose Study in Patients with Primary Immune Thrombocytopenia

Tadeusz Robak, MD, Maciej Kaźmierczak, Isidro Jarque, Vasile Musteata, MD PhD, Jacek Trelinski, Nichola Cooper, MD MRCP, Peter Kiessling, Ute Massow, Franz Woltering, Rose Snipes, Juan Ke, Grant Langdon, Birgit Haier, James B. Bussel, MD, Stephen Jolles

Blood (2019) 134 (Supplement_1): 897.

https://doi.org/10.1182/blood-2019-129839

Published: 2019

Journal Articles

SAMD9 and SAMD9L Germline Disorders in Patients Enrolled in Studies of the European Working Group of MDS in Childhood (EWOG-MDS): Prevalence, Outcome, Phenotype and Functional Characterisation

Blood (2018) 132 (Supplement 1): 643.

https://doi.org/10.1182/blood-2018-99-118389

Published: 2018

Journal Articles

Autoimmune Neutropenia of Infancy- Unexpected Prevalence of Pseudomonas Skin Infections

Joanne Yacobovich, MD, Neta Aviran Dagan, MD, Tracie Goldberg, MD, Orna Steinberg Shemer, MD MSc, Hannah Tamary, MD

Blood (2018) 132 (Supplement 1): 4940.

https://doi.org/10.1182/blood-2018-99-113408

Published: 2018

Journal Articles

The Role of Nestin + Mesenchymal Stem Cells (MSCs) in Bone Marrow Chronic Graft-Versus-Host Disease

Haiyan Zhang, Kaibo Yang, Yanqiu Chen, Hua Jin, Qifa Liu, MD

Blood (2018) 132 (Supplement 1): 2039.

https://doi.org/10.1182/blood-2018-99-113230

Published: 2018

Journal Articles

Human Papillomavirus (HPV)--Specific T-Cells Can be Generated from Unimmunized Donors for Third Party Cell Therapy of HPV-Associated Neoplasms

Conrad Russell Young Cruz, MD PhD, Sarah McCormack, BA, Kaylor Elizabeth Wright, BS, Allison B Powell, BS, Haili Lang, MS, Cecilia Barese, MDPhD, Connie Trimble, MD, Michael Keller, MD, Ephraim J. Fuchs, MD MBA, Catherine M. Bollard, MD FRACP, FRCPA

Blood (2017) 130 (Supplement 1): 1923.

https://doi.org/10.1182/blood.V130.Suppl_1.1923.1923

Published: 2017

Journal Articles

Von Willebrand Disease Screening in Women Undergoing Hysterectomy for Heavy Menstrual Bleeding

Amanda E. Jacobson, MD, Sara K. Vesely, PhD MPH, Terah Koch, MPH, Janis Campbell, PhD GISP, Sarah H. O'Brien, MD MSc

Blood (2017) 130 (Supplement 1): 674.

https://doi.org/10.1182/blood.V130.Suppl_1.674.674

Published: 2017

Journal Articles

GATA2 in Bone Marrow Failure

Steven M. Holland, MD

Blood (2017) 130 (Supplement 1): SCI-23.

https://doi.org/10.1182/blood.V130.Suppl_1.SCI-23.SCI-23

Published: 2017

Journal Articles

Erectile Dysfunction after Allogeneic Hematopoietic Stem Cell Transplant: Results from a Single Center Experience

Angelo Andreini, Nicola Zampieri, Claudio Costantini, Giovanni Malerba, Costanza Bruno, Gianluca Salvagno, Giuseppe Francia, Michele Gottardi, Michela Rimondini, Giuseppe Lippi, Isacco Ferrarini, Fabio Benedetti, Giovanni Pizzolo, Cristina Tecchio

Blood (2017) 130 (Supplement 1): 4530.

https://doi.org/10.1182/blood.V130.Suppl_1.4530.4530

Published: 2017

Journal Articles

Phase II, Multiple-Dose Study of Anti-FcRn Antibody, Rozanolixizumab (UCB7665), in Patients with Primary Immune Thrombocytopenia: Interim Analysis

Tadeusz Robak, Isidro Jarque, Vasile Musteata, Peter Kiessling, Ute Massow, James Higginson, Rose Snipes, Stephen Jolles

Blood (2017) 130 (Supplement 1): 15.

https://doi.org/10.1182/blood.V130.Suppl_1.15.15

Published: 2017

Journal Articles

Germline SAMD9 and SAMD9L Alterations in Adult Myelodysplastic Syndromes

Yasunobu Nagata, MD PhD, Bartlomiej P. Przychodzen, MSc, Cassandra M. Hirsch, BS, Hideki Makishima, MD PhD, Victor Pastor Loyola, MSc, Babal K Jha, PhD, Teodora Kuzmanovic, BA, Tomas Radivoyevitch, PhD, Vera Adema, PhD, Kenichi Yoshida, MD PhD, Samuel Li, BA, Francesc Sole, PhD, Thomas Laframboise, PhD, Rabi Hanna, MD, Mikkael A. Sekeres, MD MS, Seishi Ogawa, MD PhD, Marcin W. Wlodarski, MD PhD, Jorg Cammenga, MD, Jaroslaw P. Maciejewski, PhD MD FACP

Blood (2017) 130 (Supplement 1): 1670.

https://doi.org/10.1182/blood.V130.Suppl_1.1670.1670

Published: 2017

Journal Articles

Patient-Reported Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Types and Severity of Chronic Gvhd

Saiko Kurosawa, MD, Kumi Oshima, Takuhiro Yamaguchi, Atsumi Yanagisawa, Takahiro Fukuda, Heiwa Kanamori, MD, Takehiko Mori, MD PhD, Satoshi Takahashi, MD PhD, Tadakazu Kondo, MD PhD, Akio Kohno, Aika Seto, MD, Yukari Umemoto, Takanori Teshima, MD PhD, Shuichi Taniguchi, MD PhD, Takuya Yamashita, Yoshiko Atsuta, MD PhD

Blood (2016) 128 (22): 1240.

https://doi.org/10.1182/blood.V128.22.1240.1240

Published: 2016

Journal Articles

Mortality Among Women with Sickle Cell Disease Admitted for Delivery, California 2004-2014

Faith S. Raider, MA, Susan Paulukonis, MA, MPH, Ward Hagar, MD, Marsha J Treadwell, PhD, Mary Hulihan, MPH, PhD

Blood (2016) 128 (22): 2332.

https://doi.org/10.1182/blood.V128.22.2332.2332

Published: 2016

Journal Articles

Extensive Chronic Graft-Versus-Host-Disease Significantly Increases the Risk of Severe and Multifocal Genital Tract HPV Disease in Long-Term Survivors of Allogeneic Stem Cell Transplantation

Dana L Shanis, MD, Prathima Anandi, MD, Caitlin Grant, Priyanka A Pophali, MD, Eleftheria Koklanaris, Bipin N. Savani, MD, Austin John Barrett, MDFRCP,FRCPath, Minoo Battiwalla, MD MS, Pamela Stratton, MD

Blood (2015) 126 (23): 1956.

https://doi.org/10.1182/blood.V126.23.1956.1956

Published: 2015

Journal Articles

Impairment of IL-17 Immunity to Candida and IFN-g Immunity to Mycobacterium in Humans with Bi-Allelic Rorc mutations

Satoshi Okada, MD PhD, Janet Markle, PhD, Masao Kobayashi, MD PhD, Jacinta Bustamante, MD PhD, Jean-Laurent Casanova, MD PhD

Blood (2015) 126 (23): 205.

https://doi.org/10.1182/blood.V126.23.205.205

Published: 2015

Journal Articles

Dominant NFKB1 Mutations Cause Antibody Deficiency and Autoinflammatory Episodes

Blood (2015) 126 (23): 206.

https://doi.org/10.1182/blood.V126.23.206.206

Published: 2015

Journal Articles

Colchicine Can be an Effective Adjunctive Treatment for Extensive Refractory Chronic-Graft-Versus-Host Disease

Sandy W. Wong, MD, Raymond L. Comenzo, MD, Todd F. Roberts, MD MSC, FRCP (C), Kellie Sprague, MD, Kenneth B. Miller, MD

Blood (2015) 126 (23): 5461.

https://doi.org/10.1182/blood.V126.23.5461.5461

Published: 2015

Journal Articles

Secondary Malignancies in Chronic Lymphocytic Leukemia: A Single Centre Retrospective Analysis of 514 Cases

Gianluigi Reda, MD, Bruno Fattizzo, MD, Ramona Cassin, MD, Nicola Orofino, MD, Elena Flospergher, MD, Alessandra Iurlo, MD PhD, Wilma Barcellini, MD, Agostino Cortelezzi, MD

Blood (2015) 126 (23): 5279.

https://doi.org/10.1182/blood.V126.23.5279.5279

Published: 2015

Journal Articles

Mutation Profiling of Therapy-Related Myeloid Neoplasms Using Next-Generation Sequencing Demonstrates Distinct Profiles from De Novo Disease

Alan H. Shih, MDPhD, Franck Rapaport, PhD, Stephen S. Chung, MD, Emily K Dolezal, Sean Hobson, MA, Mary K Amato, Christopher Y. Park, MD PhD, Mikkael A. Sekeres, MD MS, Marcel R.M. van den Brink, MD PhD, Stephen Nimer, MD, Ross L. Levine, MD, Jaroslaw P. Maciejewski, MD PhD, Virginia M. Klimek, MD

Blood (2014) 124 (21): 4611.

https://doi.org/10.1182/blood.V124.21.4611.4611

Published: 2014

Journal Articles

Mesenchymal Stem Cells Lacking Glucose-6-Phosphatase-β Exhibit Disturbed Energy Homeostasis and Defective Adipogenesis

Hyun Sik Jun, PhD, Janice Y Chou, PhD

Blood (2014) 124 (21): 4323.

https://doi.org/10.1182/blood.V124.21.4323.4323

Published: 2014

Journal Articles

Obinutuzumab (GA101) in Combination with CHOP (Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) or Bendamustine for the First-Line Treatment of Follicular Non-Hodgkin Lymphoma: Final Results from the Maintenance Phase of the Phase Ib GAUDI Study

Martin JS Dyer, Andrew P Grigg, MBBS FRACP FRCPA MD, Marcos González Díaz, MD PhD, Martin Dreyling, Simon Rule, MD, Guiyuan Lei, PhD, Elisabeth Wassner-Fritsch, PharmD, Günter Fingerle-Rowson, MDPhD, Paula V Marlton, MBBS

Blood (2014) 124 (21): 1743.

https://doi.org/10.1182/blood.V124.21.1743.1743

Published: 2014

NARROW

Rozanolixizumab, an Anti-FcRn Antibody: Final Results from a Phase II, Multiple-Dose Study in Patients with Primary Immune Thrombocytopenia

SAMD9 and SAMD9L Germline Disorders in Patients Enrolled in Studies of the European Working Group of MDS in Childhood (EWOG-MDS): Prevalence, Outcome, Phenotype and Functional Characterisation

Autoimmune Neutropenia of Infancy- Unexpected Prevalence of Pseudomonas Skin Infections

The Role of Nestin + Mesenchymal Stem Cells (MSCs) in Bone Marrow Chronic Graft-Versus-Host Disease

Human Papillomavirus (HPV)--Specific T-Cells Can be Generated from Unimmunized Donors for Third Party Cell Therapy of HPV-Associated Neoplasms

Von Willebrand Disease Screening in Women Undergoing Hysterectomy for Heavy Menstrual Bleeding

GATA2 in Bone Marrow Failure

Erectile Dysfunction after Allogeneic Hematopoietic Stem Cell Transplant: Results from a Single Center Experience

Phase II, Multiple-Dose Study of Anti-FcRn Antibody, Rozanolixizumab (UCB7665), in Patients with Primary Immune Thrombocytopenia: Interim Analysis

Germline SAMD9 and SAMD9L Alterations in Adult Myelodysplastic Syndromes

Patient-Reported Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Types and Severity of Chronic Gvhd

Mortality Among Women with Sickle Cell Disease Admitted for Delivery, California 2004-2014

Extensive Chronic Graft-Versus-Host-Disease Significantly Increases the Risk of Severe and Multifocal Genital Tract HPV Disease in Long-Term Survivors of Allogeneic Stem Cell Transplantation

Impairment of IL-17 Immunity to Candida and IFN-g Immunity to Mycobacterium in Humans with Bi-Allelic Rorc mutations

Dominant NFKB1 Mutations Cause Antibody Deficiency and Autoinflammatory Episodes

Colchicine Can be an Effective Adjunctive Treatment for Extensive Refractory Chronic-Graft-Versus-Host Disease

Secondary Malignancies in Chronic Lymphocytic Leukemia: A Single Centre Retrospective Analysis of 514 Cases

Mutation Profiling of Therapy-Related Myeloid Neoplasms Using Next-Generation Sequencing Demonstrates Distinct Profiles from De Novo Disease

Mesenchymal Stem Cells Lacking Glucose-6-Phosphatase-β Exhibit Disturbed Energy Homeostasis and Defective Adipogenesis

Obinutuzumab (GA101) in Combination with CHOP (Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) or Bendamustine for the First-Line Treatment of Follicular Non-Hodgkin Lymphoma: Final Results from the Maintenance Phase of the Phase Ib GAUDI Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only